Three validated tools—EASI, vIGA-AD, and IGA—stand out as most useful to clinicians for atopic dermatitis documentation and assessment. Three validated tools stand out as most useful to busy clinicians who assess and document clinical signs of...
Dermatology
Authoritative medical articles, news, research, and guidelines pertaining to Dermatology General.
RELEVANT ARTICLES IN DERMATOLOGY
Immune Biomarkers for Clinical Super-Response to Guselkumab in Psoriasis
Immune Biomarkers for Clinical Super-Response to Guselkumab in Psoriasis
The following is a summary of “FC01 Higher IL-10+ T-cell and Treg-cell counts in psoriatic skin are associated with super-response to guselkumab: data from the Phase 3b GUIDE trial,” published in the December 2024 issue of Dermatology by Asadullah et al. The...
Link Between Corticosteroid Phobia and Adherence in CHE Treatment
Link Between Corticosteroid Phobia and Adherence in CHE Treatment
The following is a summary of “Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema—Findings from the Danish Skin Cohort,” published in the December 2024 issue of Dermatology by Christensen et al. Topical...
Advertisement
FDA Expands Approval of Vtama to Include Atopic Dermatitis
FDA Expands Approval of Vtama to Include Atopic Dermatitis
THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.The...
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.The approval is for use in combination with...
Determinants of Patient Treatment Choice in Bowen’s Disease
Determinants of Patient Treatment Choice in Bowen’s Disease
The following is a summary of “Patient preferences for treatment of Bowen’s disease,” published in the December 2024 issue of Dermatology by Ahmady et al. Discrete choice experiments (DCEs) are increasingly utilized to analyze and quantify patient preferences for...
Immune Biomarkers for Clinical Super-Response to Guselkumab in Psoriasis
Immune Biomarkers for Clinical Super-Response to Guselkumab in Psoriasis
The following is a summary of “FC01 Higher IL-10+ T-cell and Treg-cell counts in psoriatic skin are associated with super-response to guselkumab: data from the Phase 3b GUIDE trial,” published in the December 2024 issue of Dermatology by Asadullah et al. The...
Link Between Corticosteroid Phobia and Adherence in CHE Treatment
Link Between Corticosteroid Phobia and Adherence in CHE Treatment
The following is a summary of “Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema—Findings from the Danish Skin Cohort,” published in the December 2024 issue of Dermatology by Christensen et al. Topical...
FDA Expands Approval of Vtama to Include Atopic Dermatitis
FDA Expands Approval of Vtama to Include Atopic Dermatitis
THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.The...
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.The approval is for use in combination with...
Determinants of Patient Treatment Choice in Bowen’s Disease
Determinants of Patient Treatment Choice in Bowen’s Disease
The following is a summary of “Patient preferences for treatment of Bowen’s disease,” published in the December 2024 issue of Dermatology by Ahmady et al. Discrete choice experiments (DCEs) are increasingly utilized to analyze and quantify patient preferences for...
Advertisement
Chronic Spontaneous Urticaria
A collection of feature articles, study abstracts, and other resources all focused on chronic spontaneous urticaria (CSU).
Fall Clinical Dermatology Conference 2024
The latest news from Fall Clinical Dermatology Conference 2024 focused on psoriasis including abstracts, features, and helpful conference information.
Advertisement
What ICU Chaplains Can & Shouldn’t Do
What ICU Chaplains Can & Shouldn’t Do
ICU chaplains play a vital role in care teams, offering support in stressful times; however there are limits to what they can and should do in the hospital.
A Care Facility Comeuppance
A Care Facility Comeuppance
In this medical fiction tale, a care facility cleaner juggles workplace challenges and quirky residents while dealing with evil management intent on doing harm.
Caroling & Caring: Tips for Clinicians to Help Reduce Holiday Work Stress
Caroling & Caring: Tips for Clinicians to Help Reduce Holiday Work Stress
Coping tips for clinicians experiencing holiday work stress due to patient surges, staffing shortages, and increased inpatient emotional demands.
CME / CE
Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality
This course discusses that melanoma in situ (MIS) is not a definite precursor to invasive melanoma. While a patient’s chance of dying from melanoma is elevated (albeit low in absolute terms), their overall survival is significantly higher than that of their peers without MIS.
PODCAST
Advertisement
MORE STORIES IN DERMATOLOGY
FILTER ARTICLES BY:
Advertisement
PODCAST
CARTOONS
BUSINESS OF MEDICINE
How Physicians Can Use Data-Driven Insights to Enhance Patient Safety & Reduce Malpractice Risk
How Physicians Can Use Data-Driven Insights to Enhance Patient Safety & Reduce Malpractice Risk
Given the litigious nature of today’s world, physicians must use data-driven insights to both enhance patient safety and reduce malpractice risk.
How Healthcare Organizations Can Provide Satisfactory Physician Compensation
How Healthcare Organizations Can Provide Satisfactory Physician Compensation
Healthcare leaders must adapt swiftly, updating hiring policies and physician compensation to retain talent, ensuring satisfaction and a competitive edge.
Medical Truths Behind Brain Rot
Medical Truths Behind Brain Rot
"Brain rot" is Oxford's 2024 Word of the Year, shedding light on how excessive social media use may harm mental and intellectual health.
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.